Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | TDP2 | O95551 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.36 |
| ▸ | PDE2A | O00408 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CASR | P41180 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10140385 | 0.83 | CSF1R (0.49) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL10140468 | 0.78 | HPGD (0.41) | HPGDTSHRHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL10140757 | 0.76 | PDE10A (0.41) | HPGDSMN1; SMN2ALDH1A1MAPTNPC1 | |
| SCHEMBL16258908 | 0.75 | SMN1; SMN2 (0.36) | HPGDTSHRHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL10172626 | 0.75 | CYP1A2 (0.52) | HSD17B10SMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL7972107 | 0.74 | RAB9A (0.45) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL10140871 | 0.73 | MAPT (0.39) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL10140710 | 0.73 | TP53 (0.46) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL10140393 | 0.73 | TP53 (0.48) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT | |
| SCHEMBL10140698 | 0.72 | PTGDR2 (0.39) | HPGDHSD17B10SMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148363-B2 | Heterocyclic compounds as factor IXA inhibitors | SCHERING CORPORATION (US) | 2012-04-03 | — | — | US | disclosed |
| US-20110065682-A1 | HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS | MERCK SHARP & DOHME LLC | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065682-A1 | HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS | F9, F12, F8 | HPGD 340/4885TSHR 2666/4885HSD17B10 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.